In this review, we discuss the canonical roles and stimuli of GC-C, extraintestinal effects, and how changes in GC-C-mediated signaling underpin colorectal cancer (CRC) and inflammatory bowel disease (IBD) (Figure 1). The gene discussed is GUCY2C; the disease is inflammatory bowel disease.